-
1
-
-
0023121401
-
Cholesterol and mortality. 30 years of follow-up from the Framingham study
-
Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. J Am Med Assoc 1987;257(16):2170-80.
-
(1987)
J Am Med Assoc
, vol.257
, Issue.16
, pp. 2170-2180
-
-
Anderson, K.M.1
Castelli, W.P.2
Levy, D.3
-
2
-
-
0029060065
-
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study
-
Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995;274:131-5.
-
(1995)
JAMA
, vol.274
, pp. 131-135
-
-
Verschuren, W.M.1
Jacobs, D.R.2
Bloemberg, B.P.3
-
3
-
-
0022417070
-
Risk factors for ischaemic heart disease: The prospective phase of the British Regional Heart Study
-
Sharper AG, Pocock SJ, Walker M, et al. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health 1985;39(3): 197-209.
-
(1985)
J Epidemiol Community Health
, vol.39
, Issue.3
, pp. 197-209
-
-
Sharper, A.G.1
Pocock, S.J.2
Walker, M.3
-
4
-
-
0027987849
-
Randomized trial of cholesterol lowering in 444 patients with coronary heart disease: The Scandinavian Sirrivastatin Survival Study (4S)
-
Randomized trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandinavian Sirrivastatin Survival Study (4S). Lancet 1994;44(8934):1383-9.
-
(1994)
Lancet
, vol.44
, Issue.8934
, pp. 1383-1389
-
-
-
5
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
-
Shepherd J, Cobbee SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbee, S.M.2
Ford, I.3
-
6
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
-
Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
7
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22.
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
8
-
-
0035897696
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Executive Summary of the Third Report of the National Cholesterol Education Program NCEP
-
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
9
-
-
0036954887
-
-
National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Full report. September 2002. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/ atp3_rpt.htm. Accessed November 2, 2004. Can J Cardiol 1993;9:405-12.
-
National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Full report. September 2002. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/ atp3_rpt.htm. Accessed November 2, 2004. Can J Cardiol 1993;9:405-12.
-
-
-
-
10
-
-
33748353843
-
Impacts of cost contaimnent strategies on pharmaceutical expenditures of the National Health Insurance in Taiwan, 1996-2003
-
Lee YC, Yang MC, Huang YT, et al. Impacts of cost contaimnent strategies on pharmaceutical expenditures of the National Health Insurance in Taiwan, 1996-2003. Pharmacoeconomics 2006: 24(9):891-902.
-
(2006)
Pharmacoeconomics
, vol.24
, Issue.9
, pp. 891-902
-
-
Lee, Y.C.1
Yang, M.C.2
Huang, Y.T.3
-
11
-
-
0038721595
-
The Bioequivalence and Theurapeutic Efficacy of Generic Versus Brand-name Psychoactive Drugs
-
Giuseppe Borgherini. The Bioequivalence and Theurapeutic Efficacy of Generic Versus Brand-name Psychoactive Drugs. Clin Ther 2003;25(6):1578-92.
-
(2003)
Clin Ther
, vol.25
, Issue.6
, pp. 1578-1592
-
-
Borgherini, G.1
-
12
-
-
0035073507
-
United States Food and Drug Administration requirements for approval of generic drug products
-
Meyer MC. United States Food and Drug Administration requirements for approval of generic drug products. J Clin Psychiatry 2001;62(Suppl 5):4-9.
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 5
, pp. 4-9
-
-
Meyer, M.C.1
-
13
-
-
84855752822
-
-
Office of Generic Drugs, Available at:, 16th August, 2007
-
Office of Generic Drugs. US Food and Drug Administration Web site. Available at: http//www.fda.gov/cder/cder/ogd/. (16th August, 2007)
-
US Food and Drug Administration Web site
-
-
-
14
-
-
0038632965
-
Generic: Not all drugs are created equal
-
Cantor LB. Generic: Not all drugs are created equal. Rev Ophthalmol 2002;9:72-4.
-
(2002)
Rev Ophthalmol
, vol.9
, pp. 72-74
-
-
Cantor, L.B.1
-
15
-
-
0033049802
-
Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease
-
Schaefer JR, Schweer H, Ikewaki K, et al. Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease. Atherosclerosis 1999;144:177-84.
-
(1999)
Atherosclerosis
, vol.144
, pp. 177-184
-
-
Schaefer, J.R.1
Schweer, H.2
Ikewaki, K.3
-
16
-
-
3042681157
-
Are the effects of statins on LDL-cholesterol clinically relevant?
-
Chapman MJ. Are the effects of statins on LDL-cholesterol clinically relevant? Eur Heart J 2004;6(Suppl C):C58-C63.
-
(2004)
Eur Heart J
, vol.6
, Issue.SUPPL. C
-
-
Chapman, M.J.1
|